These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19770002)

  • 21. Chronic prenatal ethanol exposure alters hippocampal GABA(A) receptors and impairs spatial learning in the guinea pig.
    Iqbal U; Dringenberg HC; Brien JF; Reynolds JN
    Behav Brain Res; 2004 Apr; 150(1-2):117-25. PubMed ID: 15033285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The plasma-occupancy relationship of the novel GABAA receptor benzodiazepine site ligand, alpha5IA, is similar in rats and primates.
    Atack JR; Eng WS; Gibson RE; Ryan C; Francis B; Sohal B; Dawson GR; Hargreaves RJ; Burns HD
    Br J Pharmacol; 2009 Jul; 157(5):796-803. PubMed ID: 19422390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-lasting correction of in vivo LTP and cognitive deficits of mice modelling Down syndrome with an α5-selective GABA
    Duchon A; Gruart A; Albac C; Delatour B; Zorrilla de San Martin J; Delgado-García JM; Hérault Y; Potier MC
    Br J Pharmacol; 2020 Mar; 177(5):1106-1118. PubMed ID: 31652355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rodent pharmacokinetics and receptor occupancy of the GABAA receptor subtype selective benzodiazepine site ligand L-838417.
    Scott-Stevens P; Atack JR; Sohal B; Worboys P
    Biopharm Drug Dispos; 2005 Jan; 26(1):13-20. PubMed ID: 15578749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basmisanil, a highly selective GABA
    Hipp JF; Knoflach F; Comley R; Ballard TM; Honer M; Trube G; Gasser R; Prinssen E; Wallace TL; Rothfuss A; Knust H; Lennon-Chrimes S; Derks M; Bentley D; Squassante L; Nave S; Nöldeke J; Wandel C; Thomas AW; Hernandez MC
    Sci Rep; 2021 Apr; 11(1):7700. PubMed ID: 33833333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The discovery and unique pharmacological profile of RO4938581 and RO4882224 as potent and selective GABAA alpha5 inverse agonists for the treatment of cognitive dysfunction.
    Knust H; Achermann G; Ballard T; Buettelmann B; Gasser R; Fischer H; Hernandez MC; Knoflach F; Koblet A; Stadler H; Thomas AW; Trube G; Waldmeier P
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5940-4. PubMed ID: 19762240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Etomidate targets alpha5 gamma-aminobutyric acid subtype A receptors to regulate synaptic plasticity and memory blockade.
    Martin LJ; Oh GH; Orser BA
    Anesthesiology; 2009 Nov; 111(5):1025-35. PubMed ID: 19809285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3-phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and analogues: high-affinity gamma-aminobutyric acid-A benzodiazepine receptor ligands with alpha 2, alpha 3, and alpha 5-subtype binding selectivity over alpha 1.
    Carling RW; Moore KW; Street LJ; Wild D; Isted C; Leeson PD; Thomas S; O'Connor D; McKernan RM; Quirk K; Cook SM; Atack JR; Wafford KA; Thompson SA; Dawson GR; Ferris P; Castro JL
    J Med Chem; 2004 Mar; 47(7):1807-22. PubMed ID: 15027873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of GABAA alpha5-containing receptors in ethanol reward: the effects of targeted gene deletion, and a selective inverse agonist.
    Stephens DN; Pistovcakova J; Worthing L; Atack JR; Dawson GR
    Eur J Pharmacol; 2005 Dec; 526(1-3):240-50. PubMed ID: 16253225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates.
    Atack JR; Wafford KA; Tye SJ; Cook SM; Sohal B; Pike A; Sur C; Melillo D; Bristow L; Bromidge F; Ragan I; Kerby J; Street L; Carling R; Castro JL; Whiting P; Dawson GR; McKernan RM
    J Pharmacol Exp Ther; 2006 Jan; 316(1):410-22. PubMed ID: 16183706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
    Decker MW; Brioni JD; Sullivan JP; Buckley MJ; Radek RJ; Raszkiewicz JL; Kang CH; Kim DJ; Giardina WJ; Wasicak JT
    J Pharmacol Exp Ther; 1994 Jul; 270(1):319-28. PubMed ID: 7913497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The in vivo properties of pagoclone in rat are most likely mediated by 5'-hydroxy pagoclone.
    Atack JR; Pike A; Marshall G; Stanley J; Lincoln R; Cook SM; Lewis RT; Blackaby WP; Goodacre SC; McKernan RM; Dawson GR; Wafford KA; Reynolds DS
    Neuropharmacology; 2006 May; 50(6):677-89. PubMed ID: 16430927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepines as potent and highly selective GABAA alpha5 inverse agonists with potential for the treatment of cognitive dysfunction.
    Buettelmann B; Ballard TM; Gasser R; Fischer H; Hernandez MC; Knoflach F; Knust H; Stadler H; Thomas AW; Trube G
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5958-61. PubMed ID: 19740657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents.
    van der Staay FJ; Rutten K; Bärfacker L; Devry J; Erb C; Heckroth H; Karthaus D; Tersteegen A; van Kampen M; Blokland A; Prickaerts J; Reymann KG; Schröder UH; Hendrix M
    Neuropharmacology; 2008 Oct; 55(5):908-18. PubMed ID: 18674549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
    Popik P; Kostakis E; Krawczyk M; Nowak G; Szewczyk B; Krieter P; Chen Z; Russek SJ; Gibbs TT; Farb DH; Skolnick P; Lippa AS; Basile AS
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1244-52. PubMed ID: 16971504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GABAB receptor agonist baclofen improves methamphetamine-induced cognitive deficit in mice.
    Arai S; Takuma K; Mizoguchi H; Ibi D; Nagai T; Kamei H; Kim HC; Yamada K
    Eur J Pharmacol; 2009 Jan; 602(1):101-4. PubMed ID: 19028488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rat pharmacokinetics and pharmacodynamics of a sustained release formulation of the GABAA alpha5-selective compound L-655,708.
    Atack JR; Pike A; Clarke A; Cook SM; Sohal B; McKernan RM; Dawson GR
    Drug Metab Dispos; 2006 May; 34(5):887-93. PubMed ID: 16455808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in hippocampal GABAA receptor subunit composition in bipolar 1 disorder.
    Dean B; Scarr E; McLeod M
    Brain Res Mol Brain Res; 2005 Aug; 138(2):145-55. PubMed ID: 15950312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-dependent EEG effects of zolpidem provide evidence for GABA(A) receptor subtype selectivity in vivo.
    Visser SA; Wolters FL; van der Graaf PH; Peletier LA; Danhof M
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1251-7. PubMed ID: 12604703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spatial acquisition in the Morris water maze and hippocampal long-term potentiation in the adult guinea pig following brain growth spurt--prenatal ethanol exposure.
    Byrnes ML; Richardson DP; Brien JF; Reynolds JN; Dringenberg HC
    Neurotoxicol Teratol; 2004; 26(4):543-51. PubMed ID: 15203176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.